Accent pacemakers are designed to enhance patient safety, improve clinic efficiencies and deliver tailored therapy.
Remote monitoring and follow-up are designed to provide earlier detection of clinical events.
- Remote monitoring technology enables the transmission of patient data to clinicians — providing more timely notification of changes in device and patient disease status.
- Programmable, audible alerts can notify patients to any arrhythmia or device changes.
- Industry-leading longevity of 9 years* (dual chamber) is supported by a seven-year warranty1.
Remote monitoring provides key diagnostic information automatically.
- Remote follow-up via the Merlin@home® transmitter supports clinic efficiencies by allowing scheduled follow-ups to happen from home, thus promoting patient compliance.
- Interactive DirectCall® Message voice response system eliminates the need for routine follow-up calls.
- Comprehensive diagnostics, available through Merlin.net PCN, may replace the need for routine office visits.
Flexible programmability delivers optimal therapy based on patient needs.
- SenseAbility® technology provides programming flexibility for accurate sensing over a wide range of atrial and ventricular signals by adjusting during every beat.
- Ventricular Intrinsic Preference (VIP®**) is proven2 to reduce unnecessary RV pacing—which has been shown to reduce the risk of heart failure3,4—while supporting the ventricle for every non-conducted beat, to promote AV synchrony.
- Ventricular AutoCapture™ Pacing System addresses changing thresholds by automatically controlling pacing amplitude and monitoring ventricular capture with every pacing pulse.
- AF Suppression™** technology is clinically proven to suppress episodes of paroxysmal and persistent AF5.
*
**
1
2
3
4
5 |
With stored electrograms turned on
Not available in the Accent SR RF single-chamber pacemaker
From internal bench testing. Data on file at St. Jude Medical. Refers to in-clinic interrogation of the device via the Merlin Patient Care System programmer.
Hannah G et al. Reduction of ventricular pacing in pacemaker patients using Ventricular Intrinsic Preference: preliminary results from the VIP trial. Europace Supplement, July 2008.
Wilkoff BL, Cook JR, Epstein E, et al. DAVID Investigators. Dual-Chamber Pacing or Ventricular Backup Pacing in Patients With an Implantable Defibrillator. Journal of the American Medical Association 2002. 288 (24): 3115-3123.
Olshansky B, Day JD, Moore S, et al. Is Dual-Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) Study. Circulation 2007. 115: 9-16.
Carlson M, Ip J, et al. A new pacemaker algorithm for the treatment of atrial fibrillation, results of the atrial dynamic overdrive pacing trial (ADOPT). Journal of the American College of Cardiology. 2003:42:626-633. |